arrow
R

Refik Pul

university
H指数:32
被引数:4,008

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy

氯达拉滨片在多发性硬化治疗中实现无治疗缓解是否是一个现实的目标?关于氯达拉滨片作用机制及免疫重建的临床意义的新见解

2025-11-270
OAAI
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab

经奥瑞利珠单抗清除CD20后,血清中κ游离轻链浓度降低。

2025-08-220
OAAI
Association of body mass index and clinical response in patients receiving ofatumumab for treatment of multiple sclerosis

接受ofatumumab治疗多发性硬化症的患者的体重指数和临床反应的关联

2025-03-010
PRE
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
2024-11-122
PRE
Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients

新诊断的多发性硬化症患者中伴发自身免疫性疾病和抗体的患病率

2024-11-120
OAAI
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks
2024-11-040
OAAI
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disease
2024-11-011
OA